Streetbeat News

INCR

InterCure Ltd.

https://www.intercure.co

Industry

Drug Manufacturers - Specialty & Generic

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Open

1.60

Mkt cap

75M

Volume

13K

High

1.62

P/E Ratio

-4.00

52-wk high

3.72

Low

1.57

Div yield

N/A

52-wk low

1.17

InterCure announced its preliminary 2023 revenue of NIS 351 million and EBITDA of over NIS 50 million. This financial update is significant for investors tracking the company's performance.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:12 pm

InterCure Ltd. (NASDAQ:INCR), a leading medical cannabis company, provided an update on its Nir Oz facility in Southern Israel, affected by the ongoing war situation declared on October 7, 2023. The site has limited access and is partially used by the IDF. Restoration efforts are underway, and the company is seeking full compensation from the Israeli government for damages. InterCure is committed to supporting patient communities and plans to file its preliminary and full financial results for 2023 in early 2024.

Portfolio Pulse from Happy Mohamed

February 13, 2024 | 10:04 pm

InterCure has signed a definitive agreement to acquire the Leon Cannabis Pharmacy Chain. Upon closing, InterCure will issue between 1,755,000 to 1,845,000 shares to the sellers, with the exact number depending on InterCure's share price at the time of completion.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 2:23 pm

InterCure has won an arbitration proceeding against Cannolam. As a result, InterCure now holds 100% of the shares in Cannolam. The amount owed will be determined and paid as part of a full separation process.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:54 pm

InterCure Ltd. (NASDAQ:INCR), a leading medical cannabis company in Israel, has provided an update on the security situation in Israel and its impact on the company and its employees. The company's main facility is located in Kibbutz Nir Oz, near the Gaza border, which has been affected by recent attacks from Hamas terrorists. Despite the challenges, the company's management, cannabis trading houses, and pharmacies are working diligently to meet the growing demand for the company's products.

Portfolio Pulse from Charles Gross

October 17, 2023 | 9:07 pm

InterCure Ltd. (NASDAQ:INCR), doing business as Canndoc, reported a 14% YoY revenue growth for 1H 2023, totaling CA$75 million ($55.4 million). However, operating profit and adjusted EBITDA were down compared to the same period in 2022. The company is optimistic about new cannabis regulations in Israel and Germany and potential opportunities in the U.S. following a reclassification of cannabis by the DEA. InterCure's shares traded 1.86% higher in the pre-market session on Friday.

Portfolio Pulse from Jelena Martinovic

September 01, 2023 | 1:48 pm

Intercure (NASDAQ:INCR) reported a decrease in quarterly earnings from $0.17 per share last year to $0.03 per share this year, a drop of 82.35%. However, the company's sales increased by 14.29% from $50.05 million to $57.20 million over the same period.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 5:46 am

The article lists the cannabis stocks that gained and lost on August 24, 2023. Notable gainers include EVIO, Red White & Bloom Brands, and CBD Unlimited. Major losers include Choom Holdings, Radient Technologies, and Target Group.

Portfolio Pulse from Benzinga Insights

August 24, 2023 | 9:30 pm

The cannabis sector experienced mixed performance on August 21, 2023, with several stocks seeing significant gains, while others suffered losses. Notable gainers include Radient Technologies (OTC:RDDTF), Trees (OTC:CANN), and 1933 Industries (OTC:TGIFF), while Red White & Bloom Brands (OTC:RWBYF), CBD Of Denver (OTC:CBDD), and Tetra Bio Pharma (OTC:TBPMF) were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 9:30 pm

On August 18, 2023, several cannabis stocks experienced significant price movements. Notable gainers include Australis Capital (OTC:AUSAF), Target Group (OTC:CBDY), and 1606 (OTC:CBDW), with shares closing up 900.00%, 63.64%, and 44.68% respectively. On the other hand, Panacea Life Sciences (OTC:PLSH), MGC Pharmaceuticals (OTC:MGCLF), and 1933 Industries (OTC:TGIFF) were among the biggest losers, with shares closing down 24.00%, 23.33%, and 19.00% respectively.

Portfolio Pulse from Benzinga Insights

August 18, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.